Development and validation of a five-immune gene prognostic risk model in colon cancer | BMC Cancer | Full Text

Development and validation of a five-immune gene prognostic risk model in colon cancer | BMC Cancer | Full Text

Development and validation of a five-immune gene prognostic risk model in colon cancer

Colon cancer is a common and highly malignant cancer. Its morbidity is rapidly increasing, and its prognosis is poor. Currently, immunotherapy is a rapidly developing therapeutic modality of colon cancer. This...

Authors:Haitao Chen, Jun Luo and Jianchun Guo

Citation:BMC Cancer 2020 20:395

Content type:Research article

Published on: 6 May 2020

• ViewFull Text
 
• ViewPDF